Before Launching Coronavirus Vaccines, These Core Principles Should be Realized

In an open letter to the biopharma industry on September 3, 2020, Dr. Jeremy M. Levin stated 'The biopharmaceutical industry is at the center of the world’s fight against Covid-19 disease, leading the effort to develop new vaccines, therapeutic medicines, and diagnostics. Over time, we expect these efforts to be successful, resulting in a range of new healthcare products for the benefit of the entire world.'

'As data begin to emerge from clinical trials of an array of vaccines and therapeutics, we believe that it is important for us in the biopharmaceutical industry to articulate the principles we see as essential for assessing these data and determining their potential value.'

'We believe that public health, and the public’s trust in new medical products, are dependent upon the integrity, transparency and objective assessment of new data as they emerge.'

Dr. Levein's letter contained various recommendations, which can be found at this link.

As of September 3rd, there are various SARS-CoV-2 preventive vaccines in late-stage clinical study, which are listed on this CoronavirusToday webpage.